We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: biomarker
MedXY News
EnglishTag

biomarker

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Circulating Metabolites as Emerging Biomarkers for Stroke Risk Prediction: Insights from the BiomarCaRE Project
Cardiologystroke riskBiomarCaRE

Circulating Metabolites as Emerging Biomarkers for Stroke Risk Prediction: Insights from the BiomarCaRE Project

By MedXY|Sep 15, 2026

A large European cohort study identifies six circulating metabolites significantly associated with future stroke risk, highlighting their potential in improving early stroke risk prediction beyond classic risk factors.

Integrating Plasma p-tau217 and APOE Genotype to Predict Cognitive Decline Across Diverse Populations
Internal Medicinecognitive impairmentKiểu gen APOE

Integrating Plasma p-tau217 and APOE Genotype to Predict Cognitive Decline Across Diverse Populations

By MedXY|Sep 13, 2026

This pooled analysis of seven multi-ethnic cohorts demonstrates the combined prognostic value of plasma phosphorylated tau 217 concentrations and APOE-ε4 genotype for predicting risk and timing of cognitive impairment, emphasizing biomarker

Impact of Mutated p53 on Type I Interferon Pathway Expression in Endometrial Cancer: Immune Modulatory Insights
newsI型インターフェロンimmune signaling

Impact of Mutated p53 on Type I Interferon Pathway Expression in Endometrial Cancer: Immune Modulatory Insights

By MedXY|Sep 12, 2026

This study reveals distinct alterations in the type I interferon pathway expression and signaling linked to mutated p53 subtypes in endometrial cancer, highlighting differing immune microenvironments that impact prognosis and therapeutic co

Extracellular Vesicles as Liquid Biopsy Biomarkers Predicting Immune Checkpoint Therapy Resistance in Hepatocellular Carcinoma
Gastroenterologyimmune checkpoint inhibitorsimmunotherapy resistance

Extracellular Vesicles as Liquid Biopsy Biomarkers Predicting Immune Checkpoint Therapy Resistance in Hepatocellular Carcinoma

By MedXY|Aug 9, 2026

Circulating extracellular vesicles carrying PD-1, PD-L1, and CTLA-4 can non-invasively predict responses and early resistance to immune checkpoint inhibitors in advanced hepatocellular carcinoma, improving patient stratification and managem

Metabolomic Clock Links Plasma Metabolites to Ageing, Frailty, and Cognitive Decline
Diabetes & EndocrinologymetabolomicsFrailty

Metabolomic Clock Links Plasma Metabolites to Ageing, Frailty, and Cognitive Decline

By MedXY|Jul 26, 2026

A metabolomic clock based on plasma metabolites accurately estimated chronological age (r=0.92) and was associated with mortality, frailty, and cognitive impairment across two European cohorts.

Hyperreflective Abnormal Areas in Middle Retinal Layers via En Face OCT: A Novel Biomarker for Diabetic Retinopathy Risk Stratification
Diabetes & EndocrinologybiomarkerHyperreflective Abnormal Areas

Hyperreflective Abnormal Areas in Middle Retinal Layers via En Face OCT: A Novel Biomarker for Diabetic Retinopathy Risk Stratification

By MedXY|Jul 15, 2026

Hyperreflective abnormalities in middle retinal layers detected by en face OCT improve diagnostic discrimination of referable diabetic retinopathy, offering a promising adjunct biomarker beyond clinical parameters.

Fecal Calprotectin as a Biomarker for Diagnosis and Monitoring of Gastrointestinal Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Clinical UpdatesAllo-HSCTbiomarker

Fecal Calprotectin as a Biomarker for Diagnosis and Monitoring of Gastrointestinal Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

By MedXY|Jun 26, 2026

Fecal calprotectin offers a non-invasive, dynamic biomarker to predict, diagnose, and monitor GI-GVHD post-allo-HSCT, correlating with endoscopic severity and treatment response, but requires integrated clinical interpretation due to limite

Thyroid Hormones May Offer a New Therapeutic and Prognostic Angle in ADPKD
Diabetes & EndocrinologyADPKDbiomarker

Thyroid Hormones May Offer a New Therapeutic and Prognostic Angle in ADPKD

By MedXY|Jun 19, 2026

Thyroid hormone signaling may influence ADPKD progression, with preclinical cyst suppression and patient biomarker associations suggesting prognostic and therapeutic potential.

A Three-miRNA Plasma Signature May Help Detect Early Beta Cell Dysfunction Before Overt Type 2 Diabetes Progression
Diabetes & Endocrinologybeta cell dysfunctionbiomarker

A Three-miRNA Plasma Signature May Help Detect Early Beta Cell Dysfunction Before Overt Type 2 Diabetes Progression

By MedXY|Jun 10, 2026

Plasma profiling identified a three-miRNA panel associated with beta cell rate sensitivity across glucose tolerance stages, suggesting a minimally invasive approach to detect early insulin secretory decline.

Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus
Critical CarebiomarkerNORSE

Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus

By MedXY|Jun 10, 2026

This study found that cryptogenic NORSE causes severe, rapidly rising neuroaxonal injury, measured by NfL, and that higher NfL predicts worse short-term outcome. S100B was not useful for distinguishing groups.

Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma
Hematology-Oncologybiomarkernasopharyngeal carcinoma

Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma

By MedXY|May 25, 2026

P85-Ab, an anti-EBV BNLF2b antibody test, showed excellent accuracy for suspected nasopharyngeal carcinoma and outperformed older EBV markers in most outpatient settings.

Protein Misfolding in the Gut: A Window into Future Neurodegeneration
Gastroenterologybiomarkergastrointestinal biopsy

Protein Misfolding in the Gut: A Window into Future Neurodegeneration

By MedXY|Apr 23, 2026

GI biopsies reveal misfolded proteins years before neurological symptoms appear, offering a new biomarker for early neurodegenerative disease prediction and intervention.

A Blood-Based Extracellular Vesicle RNA Signature May Offer a New Way to Diagnose Chronic Pancreatitis
Gastroenterologybiomarkerchronic pancreatitis

A Blood-Based Extracellular Vesicle RNA Signature May Offer a New Way to Diagnose Chronic Pancreatitis

By MedXY|Apr 20, 2026

A five-RNA extracellular vesicle signature showed strong diagnostic performance for chronic pancreatitis and may also reflect acinar-to-ductal metaplasia and disease-related metabolic features.

Blood Eosinophil Count at COPD Exacerbation Predicts Long-Term Cardiovascular Risk: A Retrospective Cohort Study
Cardiologybiomarkercardiovascular events

Blood Eosinophil Count at COPD Exacerbation Predicts Long-Term Cardiovascular Risk: A Retrospective Cohort Study

By MedXY|Apr 11, 2026

A large retrospective cohort study of 143,517 patients reveals that non-eosinophilic acute exacerbations of COPD carry a significantly higher one-year risk of major adverse cardiovascular events compared with eosinophilic exacerbations, sug

Revolutionizing Endometriosis Diagnosis: Validation of a Saliva-Based microRNA Signature
newsbiomarkerdiagnosis

Revolutionizing Endometriosis Diagnosis: Validation of a Saliva-Based microRNA Signature

By MedXY|Oct 30, 2025

A prospective multicenter study validates the high accuracy of a saliva microRNA signature for noninvasive endometriosis diagnosis, demonstrating superior performance to imaging modalities and promising clinical utility.

Proteogenomic Insights into Personalized Adjuvant Chemotherapy for Extrahepatic Cholangiocarcinoma
Gastroenterologyadjuvant chemotherapybiomarker

Proteogenomic Insights into Personalized Adjuvant Chemotherapy for Extrahepatic Cholangiocarcinoma

By MedXY|Oct 28, 2025

Comprehensive proteogenomic profiling in resected extrahepatic cholangiocarcinoma reveals predictive biomarkers for tailoring adjuvant chemotherapy, offering a precision medicine approach to improve patient outcomes.

RIPK3 as a Prognostic Biomarker in Acute Decompensation of Cirrhosis: Advancing Risk Stratification and Therapeutic Targeting
Critical CareACLFbiomarker

RIPK3 as a Prognostic Biomarker in Acute Decompensation of Cirrhosis: Advancing Risk Stratification and Therapeutic Targeting

By MedXY|Oct 28, 2025

RIPK3-associated necroptosis critically drives organ failure and mortality in acute decompensation and ACLF, with its plasma levels robustly predicting outcomes and improving prognostic models to guide personalized therapies.

Blood Test Breakthrough: Detecting ALS Over a Decade Before Symptoms Emerge
Medical NewsALSbiomarker

Blood Test Breakthrough: Detecting ALS Over a Decade Before Symptoms Emerge

By MedXY|Oct 6, 2025

New research identifies a protein signature in blood that detects ALS years before symptoms, challenging previous perceptions and offering hope for early diagnosis and intervention.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story